Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Articles online first > Minerva Cardioangiologica 2016 Nov 23



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


Minerva Cardioangiologica 2016 Nov 23

Current aspects of pulmonary arterial hypertension and therapeutics

Xianchi LI, Yuanyuang LIU, Peiying ZHANG

Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China

The pulmonary arterial hypertension (PAH) patients have high raet of morlatility due to right ventricle (or ventricular) (RV) failures. A lot of research work is being carried out in the area, however no treatments is available that could mange above rise in morality rates in PAH patients. β1-adrenoceptor blockers (β-blockers, BB) reduced mortality in left heart failure but they not much explored much at clinical level. Recent studies suggest β- blockers might be beneficial in PAH however the mechanisms remain unknown. The present review article would put light on all these aspeces of PAH along with latest avenues for the management of PAH.

language: English


top of page